Prefilled Syringes Market Size, Share and Trends 2025 to 2034

Prefilled Syringes Market Size and Growth 2025 to 2034

The prefilled syringes market size accounted for USD 19.31 billion in 2024, and is anticipated to hit around USD 21.59 billion by 2025, and is expected to reach around USD 58.91 billion by 2034, expanding at a CAGR of 11.80% from 2025 to 2034.

Prefilled Syringes Market Key Takeaways

• In terms of revenue, the market is valued at $21.59 billion in 2025.
• It is projected to reach $58.91 billion by 2034.
• The market is expected to grow at a CAGR of 11.80% from 2025 to 2034.
• Europe led the global market with the highest market share of 40% in 2024.
• By Type, the safety prefilled syringes segment captured the biggest revenue share in 2024.
• By Material, the glass prefilled syringes segment is estimated to hold the highest market share in 2024.
• By Design, the single-chamber prefilled syringes segment has held the largest market share in 2024.

Europe Prefilled Syringes Market Size and Growth 2025 to 2034

The Europe prefilled syringes market size is estimated at USD 8.64 billion in 2025 and is predicted to be worth around USD 23.56 billion by 2034, at a CAGR of 11.80% from 2025 to 2034.

Europe is one of the major profit-generating regions in the prefilled syringes market. Rising frequency of chronic conditions, technological advancements, growth of the biologics and biosimilars market, geographical expansion by crucial manufacturers, growing population, and high adoption of tone-injection bias are driving the demand for tone-injectable prefilled syringes are the major factors driving the growth of the prefilled syringes market in Europe.

Due to expanding access to healthcare, increased uptake of advanced drug delivery systems, and increased awareness of patient safety, Asia Pacific is quickly becoming a growth hub for the prefilled syringe market. Furthermore, with Asia Pacific being one of the largest population bases in the world, bettering regulatory frameworks, local pharmaceutical manufacturing, and growing investments from global players, this puts the growth of the Asia Pacific region even more in focus as a key component of this market expansion.

Prefilled Syringes Market Growth Factors

A pre-filled syringe is also recognized as a package which is comprised of single-dose of medicine in which an attached needle also provided by the manufacturer. Previously, metal or glass syringes were very common in the industry of industry, but slowly & steadily consumer shift have been observed more towards disposable or plastic syringes in order to secure the needle and make it use and throw so that it cannot be re-utilized. In addition, this has revitalized the demand towards safe and convenient pre-filled syringes in the pharmaceutical market over conventional glass vials for storing drugs.

The impact of the driving factors is anticipated to surpass the effect of restraints. Also, the technological advancements leading to advanced adoption rate and untapped markets in the developing countries are anticipated to give new avenues for the growth of market in the near future. Likewise, growing use of technological advancements and prefilled syringes in auto-injectors are the crucial factors propelling the market. Furthermore, prefilled syringes are fleetly swapping traditional combinations of syringe-vial owing to advantages provided by them, similar as convenience for healthcare practitioners and increased patient safety in cure medication and delivery.

These syringes enable easy operation of chronic diseases, similar as rheumatoid arthritis, and diabetes which is anticipated to boost the use of auto-injectors and pen injectors during the forecast period. Therefore, the growing frequency of chronic disease like diabetes and other diseases is likely to fuel the market demand over the upcoming time period. In addition, the launch of advanced equipment with Wi-Fi and Bluetooth connectivity easing effective operation of patient health records is also anticipated to boost the product demand.

In addition, the usage of pre-filled syringe has skyrocketed owing to the numerous difficulties in the traditional process. There are various advantages pre-filled syringes have in place of traditional packaging in vials which comprise of ease in use. As prefilled syringes efficiently mitigate the processes which is further required before using any drug in a vial. Moreover, it further helps in removing errors while providing doses to the patient’s as prefilled syringes are importantly comprise of the exact dose required for the patient. In addition, numerous producers of pharmaceuticals overfill their vials by up to 18%, however, this overfilled of vials is likely to cause many errors while giving a dose to the patient which can easily be mitigated with the help of the pre-filled syringes. Also, there exists excessive syringes development and various new products have been launched and are being kept in syringes now for the microbial safety. Pre-filled syringes are used in the packaging of injectable and diluents drugs. Some of the majorly listed drugs packaged in pre-filled syringes includes vaccines, blood stimulants, ervthroproteins, therapeutic proteins, and rheumatoid arthritis. Thus, comfort in utilization and better safety of the drug is the major factor which is leading to rise in demand for prefilled syringes in the market.

The impact of the COVID-19 on the market is likely to be more varied owing to the upsurge manufacturing of vaccines. In addition, growing demand for similar syringes instead of glass ampoules or other alternate needles have been observed on account of the decreased trouble of needle injuries. Accordingly, in order to boost the production of the COVID-19 vaccination, the producers are increasing their manufacturing capability.

The demand for prefilled syringes has risen due to the COVID-19 pandemic. The surge in number of COVID-19 patients is paving new ways for the growth of the global prefilled syringes market during 2020. Another factor boosting the growth of the global prefilled syringes market is growing incidences of rheumatoid arthritis and diabetes all over the world. In addition, the growing concerns about the safety of injectables are propelling the prefilled syringes market. The growing technological developments in the prefilled syringes market are also driving the demand for prefilled syringes. The prefilled syringes are widely adopted in the developed and developing regions such as North America and Europe. Moreover, the surge in demand for biosimilars is also contributing to the growth of the prefilled syringes market.

Market Scope

Type Insight

On the basis of type, safety prefilled syringes segment is likely to foresee the loftiest growth during the forthcoming time period majorly owing to the growing senior population worldwide and biological therapies availabilities for patients with suffering from chronic diseases and low- threat medical procedures outsourcing for chronic patients ease some of the pressure on hospitals.

Material Insight

The glass prefilled syringes segment reckoned for the largest share of the prefilled syringes in 2024. The large share of this segment is attributed to the significant benefits offered, similar as forestallment of oxygen and water vapor from interacting with medicine composites, comity with different stuffing machines, and flawless integration into pharmaceutical companies PFS operations.

Design Insight

The single- chamber prefilled syringes segment reckoned for the largest share of the prefilled syringes market. Furthermore, the market growth is majorly attributed to the significant benefits with the usage of prefilled syringes of single-chamber over vials, similar as optimized API use with lower overfill, lower medicine waste in clinical trials, reduced material requirements, and simple storage& disposal. Also, upsurge in self-administered parenteral medicines adoption owing to the adding frequency of various chronic diseases and advantages offered by them.

Prefilled Syringes Market Companies

• SCHOTT AG
• West Pharmaceutical Services, Inc.
• Baxter International Inc.
• Weigao Group
• Vetter Pharma International GmbH
• Nipro Corporation
• Elcam Medical
• Oval Medical Technologies
• SHL Medical AG
• Terumo

Recent Developments

• In January 2025, SCHOTT Pharma, a provider of drug containment and delivery solutions, launched the next generation of SCHOTT TOPPAC infuse polymer syringes, a system designed to improve safety and efficiency. The next generation of SCHOTT TOPPAC infuse syringes can be filled on existing filling lines without requiring modifications or additional investment. (Source: https://www.contractpharma.com)  
• In May 2025, Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose prefilled syringes. Zydus’ generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone® 20 mg/ml, 40 mg/ml and indicated for the treatment of relapsing forms of Multiple Sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. (Source: https://www.businesswire.com) 
• In April 2025, Argenx announced FDA Approval of VYVGART Hytrulo Prefilled Syringe for self-injection in generalized Myasthenia Gravis and chronic inflammatory demyelinating polyneuropathy. VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe. (Source: https://www.globenewswire.com) 
• In November 2024, Affinity Whole Health, a pioneer in personalized healthcare solutions with a focus on in-home weight loss and hormone therapies, announced the introduction of its new compounded GLP-1 pre-filled syringes, a unique and patient-centric offering in the weight loss and metabolic health space. GLP-1 pre-filled syringes represent a significant step forward in making effective weight loss treatments more accessible and affordable. (Source: https://www.citybiz.co) 
• In December 2020, Becton, Dickinson and Company (BD) to invest around USD 1.2 billion to expand its manufacturing technology and capacity of prefilled syringes. This strategy enhanced the company to create strong position in the market.
• In March 2019, SCHOTT launched syriQBioPure that is world’s first lubricant free prefilled glass syringe. This innovative launch enabled the company to extend its product portfolio in this industry.

Segments Covered in the Report

By Type

• Conventional Prefilled Syringes
• Disposable Prefilled Syringes
• Reusable Prefilled Syringes
• Safety Prefilled Syringes

By Material

• Glass
• Plastic

By Design

• Single-Chamber
• Dual- Chamber
• Customized

By Product

• Complete Syringe Set
• Components and Accessories

By Application

• Diabetes
• Rheumatoid Arthritis
• Anaphylaxis
• Cancer
• Thrombosis
• Ophthalmology
• Others

By Closing System

• Staked Needle System
• Luer Cone System
• Luer Lock Form System

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Research and Manufacturing Organizations
• Others

By Geography

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa